MAP2K7 and colorectal carcinoma: In summary, we identified for the first time that SCNN1B acts as a tumor suppressor in CRC by targeting of MAPK oncogenic signaling through inactivation of c-Raf, thus impairing MEK-ERK signaling cascades.